Your browser doesn't support javascript.
loading
Safety and Immunogenicity of Inactivated Bacillus subtilis Spores as a Heterologous Antibody Booster for COVID-19 Vaccines.
Sung, Johnny Chun-Chau; Lai, Nelson Cheuk-Yin; Wu, Kam-Chau; Choi, Man-Chung; Ma, Chloe Ho-Yi; Lin, Jayman; Kuok, Cheong-Nang; Leong, Wai-Leng; Lam, Weng-Kei; Hamied, Yusuf Khwaja; Lam, Dominic Man-Kit; Sze, Eric Tung-Po; Kwong, Keith Wai-Yeung.
Afiliação
  • Sung JC; Research Department, DreamTec Cytokines Limited, Hong Kong, China.
  • Lai NC; Oristry BioTech (HK) Limited, Hong Kong, China.
  • Wu KC; Meserna Therapeutic (HK) Limited, Hong Kong, China.
  • Choi MC; L&L Immunotherapy Company Limited, Hong Kong, China.
  • Ma CH; Research Department, DreamTec Cytokines Limited, Hong Kong, China.
  • Lin J; Oristry BioTech (HK) Limited, Hong Kong, China.
  • Kuok CN; Meserna Therapeutic (HK) Limited, Hong Kong, China.
  • Leong WL; L&L Immunotherapy Company Limited, Hong Kong, China.
  • Lam WK; Research Department, DreamTec Cytokines Limited, Hong Kong, China.
  • Hamied YK; Research Department, DreamTec Cytokines Limited, Hong Kong, China.
  • Lam DM; Research Department, DreamTec Cytokines Limited, Hong Kong, China.
  • Sze ET; Research Department, DreamTec Cytokines Limited, Hong Kong, China.
  • Kwong KW; L&L Immunotherapy Company Limited, Hong Kong, China.
Vaccines (Basel) ; 10(7)2022 Jun 24.
Article em En | MEDLINE | ID: mdl-35891178

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2022 Tipo de documento: Article